Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bostjan Seruga

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Radiology and Oncology|February 3, 2016
Impact of comorbidity on the outcome in men with advanced prostate cancer treated with docetaxelAndrej Zist, Eitan Amir, Alberto F Ocana, et al.
Journal of the National Cancer Institute|September 19, 2012
Benefits and harms of detecting clinically occult breast cancerEitan Amir, Philippe L Bedard, Alberto Ocaña, et al.
Radiology and Oncology|September 2, 2014
Osteoblastic bone metastases from renal cell carcinomaVladka Salapura, Irena Zupan, Bostjan Seruga, et al.
Journal of the National Cancer Institute|July 12, 2011
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysisEitan Amir, Bostjan Seruga, Saroj Niraula, et al.
Cancer Treatment Reviews|January 27, 2010
Lapatinib and HER2 status: results of a meta-analysis of randomized phase III trials in metastatic breast cancerEitan Amir, Alberto Ocaña, Bostjan Seruga, et al.
Nutrients|February 25, 2023
Prognostic Impact of Nutritional Status on Overall Survival and Health-Related Quality of Life in Men with Advanced Prostate CancerLuka Cavka, Maja Pohar Perme, Nada Rotovnik Kozjek, et al.
The Oncologist|May 18, 2018
Meta-Research on Oncology Trials: A Toolkit for Researchers with Limited ResourcesRachel P Riechelmann, Julien Péron, Bostjan Seruga, et al.
Nature Reviews. Cancer|October 11, 2008
Cytokines and their relationship to the symptoms and outcome of cancerBostjan Seruga, Haibo Zhang, Lori J Bernstein, et al.
Cancer Metastasis Reviews|December 17, 2013
Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumorsAlberto Ocaña, Orit Freedman, Eitan Amir, et al.
Journal of the National Cancer Institute|April 30, 2010
Assessing women at high risk of breast cancer: a review of risk assessment modelsEitan Amir, Orit C Freedman, Bostjan Seruga, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Radiology and Oncology|February 3, 2016
Impact of comorbidity on the outcome in men with advanced prostate cancer treated with docetaxelAndrej Zist, Eitan Amir, Alberto F Ocana, et al.
Journal of the National Cancer Institute|September 19, 2012
Benefits and harms of detecting clinically occult breast cancerEitan Amir, Philippe L Bedard, Alberto Ocaña, et al.
Radiology and Oncology|September 2, 2014
Osteoblastic bone metastases from renal cell carcinomaVladka Salapura, Irena Zupan, Bostjan Seruga, et al.
Journal of the National Cancer Institute|July 12, 2011
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysisEitan Amir, Bostjan Seruga, Saroj Niraula, et al.
Cancer Treatment Reviews|January 27, 2010
Lapatinib and HER2 status: results of a meta-analysis of randomized phase III trials in metastatic breast cancerEitan Amir, Alberto Ocaña, Bostjan Seruga, et al.
Nutrients|February 25, 2023
Prognostic Impact of Nutritional Status on Overall Survival and Health-Related Quality of Life in Men with Advanced Prostate CancerLuka Cavka, Maja Pohar Perme, Nada Rotovnik Kozjek, et al.
The Oncologist|May 18, 2018
Meta-Research on Oncology Trials: A Toolkit for Researchers with Limited ResourcesRachel P Riechelmann, Julien Péron, Bostjan Seruga, et al.
Nature Reviews. Cancer|October 11, 2008
Cytokines and their relationship to the symptoms and outcome of cancerBostjan Seruga, Haibo Zhang, Lori J Bernstein, et al.
Cancer Metastasis Reviews|December 17, 2013
Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumorsAlberto Ocaña, Orit Freedman, Eitan Amir, et al.
Journal of the National Cancer Institute|April 30, 2010
Assessing women at high risk of breast cancer: a review of risk assessment modelsEitan Amir, Orit C Freedman, Bostjan Seruga, et al.
Pageof 9